Scavenger receptors in atherosclerosis

Current Opinion in Hematology

Volumn 4, Issue 1, 1997, Pages 41-47

  Freeman, Mason W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCAVENGER;

ATHEROGENESIS; ATHEROSCLEROSIS; BINDING AFFINITY; DRUG RECEPTOR BINDING; FOAM CELL; HUMAN; HUMAN CELL; LIPID STORAGE; LIPOPROTEIN METABOLISM; MOLECULAR RECOGNITION; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW;

EID: 0031039153     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199704010-00007     Document Type: Review

References (52)

1. Gerrity RG: The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes Into foam cells in fatty lesions. Am J Pathol 1981, 103:181-190.
2. Gerrity RG: The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. Am J Pathol 1981, 103:191-200.
3. Breslow JL: Mouse models of atherosclerosis [review]. Science 1996, 272:685-688. A very helpful introduction to the use of mice as models of human atherosclerosis, pointing out some important distinctions between the currently available genetically engineered mice that develop atheroma.
4. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M: Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 1995, 92:8264-6268.
5. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstrom J, Fuster V: Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995, 92:1565-1569.
6. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s [review]. Nature 1993, 362:801-809.
7. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979, 76:333-337.
8. Brown MS, Basu SK, Falck JR, Ho YK, Goldstein JL: The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J Supramol Struct 1980, 13:67-81.
9. Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem 1983, 52:223-261.
10. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity [review; comments]. N Engl J Med 1989, 320:915-924.
11. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M: Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 1990, 343:531-535.
12. Rohrer L, Freeman M, Kodama T, Penman M, Krieger M: Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 1990, 343:570-572.
13. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: CD 36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993, 268:11811-11816.
14. Acton SL, Scherer PE, Lodish HF, Krieger M: Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 1994, 269:21003-21009.
15. Pearson A, Lux A, Krieger M: Expression cloning of dSR-CI, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc Natl Acad Sci U S A 1995, 92:4056-4060. The cloning of the first and, to date, only SR-C member. Its involvement in Drosophila hemocyte/macrophage activities and potential role in immune function are discussed.
16. Elomaa O, Kangas M, Sahlberg C, Tuukkanen J, Sormunen R, Liakka A, Thesleff I, Kraal G, Tryggvason K: Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 1995, 80:603-609. The report describing the cloning of the third member of SR-A class of SRs. The similarity to the MSRs, binding characteristics, tissue distribution, and protein structure are all presented.
17. Christie RH, Freeman M, Hyman BT: Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am J Pathol 1996, 148:399-403.
18. Krieger M, Acton S, Ashkenas J, Pearson A, Penman M, Resnick D: Molecular flypaper, host defense, and atherosclerosis. Structure binding properties, and functions of macrophage scavenger receptors. J Biol Chem 1993, 268:4569-4572.
19. Freeman MW: Macrophage scavenger receptors. Curr Opin Lipidol 1994, 5:143-148.
20. Krieger M, Herz J: Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP) [review]. Ann Rev Biochem 1994, 63:601-637.
21. Acton S, Resnick D, Freeman M, Ekkel Y, Ashkenas J, Krieger M: The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands. J Biol Chem 1993, 268:3530-3537.
22. Doi T, Higashino K, Kurihara Y, Wada Y, Miyazaki T, Nakamura H, Uesugi S, Imanishi T, Kawabe Y, Itakura H, et al.: Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J Biol Chem 1993, 268:2126-2133.
23. Freeman M, Ashkenas J, Rees DJ, Kingsley DM, Copeland NG, Jenkins NA, Krieger M: An ancient highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci U S A 1990, 87:8810-8814.
24. Starling GC, Whitney GS, Siadak AW, Llewellyn MB, Bowen MA, Farr AG, Aruffo AA: Characterization of mouse CD8 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction. Eur J Immunol 1996, 26:738-746.
25. Whitney GS, Starling GC, Bowen MA, Modrell B, Siadak AW, Aruffo A: The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site. J Biol Chem 1995, 270:18187-18190. A potential function for the highly conserved SRCR domain found in many proteins expressed by cells of the immune system is reported.
26. Fraser I, Hughes D, Gordon S: Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 1993, 364:343-346.
27. Hughes DA, Fraser IP, Gordon S: Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs. Eur J Immunol 1995, 25:466-473. A comprehensive assessment of the tissue distribution of MSRs in the mouse.
28. Geng YJ, Hansson GK: High endothelial cells of postcapillary venules express the scavenger receptor in human peripheral lymph nodes. Scand J Immunol 1995, 42:289-296. Further evidence that the MSRs could be involved in leukocyte homing events.
29. Oquendo P, Hundt E, Lawler J, Seed B: CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 1989, 58:95-101.
30. Asch A: To tell the truth: will the real CD36 please stand up? [editorial; comment]. J Lab Clin Med 1996, 127:321-325.
31. Huh HY, Pearce SF, Yesner LM, Schindler JL, Silverstein RL: Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 1996, 87:2020-2028. A study of CD36 expression during macrophage differentiation. M-CSF promoted expression of the receptor and this was associated with oxidized LDL-mediated foam cell formation. An antibody to CD36 blocked a substantial component of the lipid uptake, arguing for an important role of CD36 in foam cell formation.
32. Pearce SF, Wu J, Silverstein RL: A carboxyl terminal truncation mutant of CD36 is secreted and binds thrombospondin: evidence for a single transmembrane domain. Blood 1994, 84:384-389.
33. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996, 272:518-520. This discovery of SR-BI's potential role as an HDL receptor is an important development in the field of lipid metabolism. Whether the postulated role of HDL in reverse transport is mediated in any way by SR-BI is not explored in this work, as the experiments report the role of the receptor in mediating cholesterol transfer from HDL to cells.
34. Fukasawa M, Hirota K, Adachi H, Mimura K, Murkami-Murofushi K, Tsujimoto M, Arai H, Inoue K: Chinese hamster ovary cells expressing a novel type of acetylated low density lipoprotein receptor. Isolation and characterization. J Biol Chem 1995, 270:1921-1927.
35. Rigotti A, Acton SL, Krieger M: The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 1995, 270:16221-16224. Another potentially important role for SR-BI and CD36 is highlighted in this study showing interactions between anionic phospholipid-containing liposomes and these two receptors. The implications for apoptosis and other macrophage-associated immune functions are discussed.
36. Fukasawa M, Adachi H, Hirota K, Tsujimoto M, Arai H, Inoue K: SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp Cell Res 1996, 222:246-250. A useful extension of the work by Rigotti et al. (J Biol Chem 1995, 270:16221-16224), in that it demonstrates binding of receptor to apoptotic cells.
37. Rhinehart-Jones T, Greenwalt DE: A detergent-sensitive 113-kDa conformer/complex of CD36 exists on the platelet surface. Arch Biochem Biophys 1996, 326:115-118.
38. Schackelford RE, Misra UK, Florine-Casteel K, Thai SF, Pizzo SV, Adams DO: Oxidized low density lipoprotein suppresses activation of NF kappa B in macrophages via a pertussis toxin-sensitive signaling mechanism. J Biol Chem 1995, 270:3475-3478. A signal transduction pathway is identified through which oxidized LDL might participate in macrophage activation events. The receptor mediating this pathway is not characterized but is likely to involve one of the known SRs or, potentially, an as yet uncharacterized member of the family.
39. Geng YJ, Holm J, Nygren S, Bruzelius M, Stemme S, Hansson GK: Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. Arterioscler Thromb Vasc Biol 1995, 15:1995-2002.
40. Naito M, Suzuki H, Mori T, Matsumoto A, Kodama T, Takahashi K: Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol 1992, 141:591-599.
41. Yla-Herituala S, Rosenfeld ME, Parthasarathy S, Sigal E, Sarkioja T, Witztum JL, Steinberg D: Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 1991, 87:1146-1152.
42. Li H, Freeman MW, Libby P: Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 1995, 95:122-133.
43. Gong Q, Pitas RE: Synergistic effects of growth factors on the regulation of smooth muscle cell scavenger receptor activity. J Biol Chem 1995, 270:21672-21678.
44. van der Kooij MA, Morand OH, Kempen HJ, van Berkel TJ: Decrease in scavenger receptor expression in human monocyte-derived macrophages treated with granulocyte macrophage colony-stimulating factor. Arterioscler Thromb Vasc Biol 1996, 16:106-114.
45. Hsu HY, Nicholson AC, Hajjar DP: Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated. J Biol Chem 1996, 271:7767-7773.
46. Horvai A, Palinski W, Wu H, Moulton KS, Kalla K, Glass CK: Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci U S A 1995, 92:5391-5395. Transgenic mice expressing a human MSR promoter constructor and a growth hormone reporter were found to be expressed in macrophages of transgenic mice. Expression in foam cells was noted.
47. Aftring RP, Freeman MW: Structure of the murine macrophage scavenger receptor gene and evaluation of sequences that regulate expression in the macrophage cell line, P388D. J Lipid Res 1995, 36:1305-1314.
48. Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky RH, Kanayama Y, Kurata Y, Matsuzawa Y: Identification of molecular defects in a subject with type I CD36 deficiency. Blood 1994, 83:3545-3552.
49. Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky RH, Nagao N, Kanakura Y, Kurata Y, Matsuzawa Y: Family studies of type II CD36 deficient subjects: linkage of a CD36 allele to a platelet-specific mRNA expression defect(s) causing type II CD36 deficiency. Thromb Haemost 1995, 74:758-763.
50. Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, Nagao N, Sekiguchi S, Kanayama Y, Kurata Y, Matsuzawa Y: Molecular basis of CD36 deficiency. Evidence that a 478C→T substitution (proline 90→serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 1995, 95:1040-1046.
51. Nozaki S, Hashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, Nakata A, Ishigami M, Miyagawa J, Kameda-Takemura K, et al.: Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest 1995, 96:1859-1865. A study of the involvement of CD36 in oxidized LDL uptake in monocytes conducted by comparing this process in normal monocytes with that found in the monocytes of individuals lacking CD36 expression.
52. Lougheed M, Steinbrecher UP: Mechanism of uptake of copper-oxidized low density lipoproteins in macrophages is dependent on its extent of oxidation. J Biol Chem 1996, 271:11798-11805. Some of the discrepant results comparing the competition in binding for SRs between acetylated LDL and oxidized LDL are shown to derive from the extent to which oxidized LDL is oxidized and the degree to which it aggregates following oxidation. The study does suggest that there may still be another oxidized LDL receptor in macrophages that is unaccounted for by the currently known receptors.